These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25408822)

  • 1. JOINT IDENTIFICATION OF IMAGING AND PROTEOMICS BIOMARKERS OF ALZHEIMER'S DISEASE USING NETWORK-GUIDED SPARSE LEARNING.
    Yan J; Huang H; Kim S; Moore J; Saykin A; Shen L
    Proc IEEE Int Symp Biomed Imaging; 2014 May; 2014():665-668. PubMed ID: 25408822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDENTIFICATION OF DISCRIMINATIVE IMAGING PROTEOMICS ASSOCIATIONS IN ALZHEIMER'S DISEASE VIA A NOVEL SPARSE CORRELATION MODEL.
    Yan J; Risacher SL; Nho K; Saykin AJ; Shen LI
    Pac Symp Biocomput; 2017; 22():94-104. PubMed ID: 27896965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting task relationships for Alzheimer's disease cognitive score prediction via multi-task learning.
    Liang W; Zhang K; Cao P; Liu X; Yang J; Zaiane OR
    Comput Biol Med; 2023 Jan; 152():106367. PubMed ID: 36516575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.
    Cavedo E; Lista S; Khachaturian Z; Aisen P; Amouyel P; Herholz K; Jack CR; Sperling R; Cummings J; Blennow K; O'Bryant S; Frisoni GB; Khachaturian A; Kivipelto M; Klunk W; Broich K; Andrieu S; de Schotten MT; Mangin JF; Lammertsma AA; Johnson K; Teipel S; Drzezga A; Bokde A; Colliot O; Bakardjian H; Zetterberg H; Dubois B; Vellas B; Schneider LS; Hampel H
    J Prev Alzheimers Dis; 2014 Dec; 1(3):181-202. PubMed ID: 26478889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology steered stratification network for subtype identification in Alzheimer's disease.
    Xu E; Zhang J; Li J; Song Q; Yang D; Wu G; Chen M
    Med Phys; 2024 Feb; 51(2):1190-1202. PubMed ID: 37522278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
    Jemimah S; AlShehhi A;
    BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Zu C; Jie B; Liu M; Chen S; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Dec; 10(4):1148-1159. PubMed ID: 26572145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning.
    Wang H; Nie F; Huang H; Risacher SL; Saykin AJ; Shen L;
    Bioinformatics; 2012 Jun; 28(12):i127-36. PubMed ID: 22689752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual feature correlation guided multi-task learning for Alzheimer's disease prediction.
    Tang S; Cao P; Huang M; Liu X; Zaiane O
    Comput Biol Med; 2022 Jan; 140():105090. PubMed ID: 34875406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network-Guided Sparse Learning for Predicting Cognitive Outcomes from MRI Measures.
    Yan J; Huang H; Risacher SL; Kim S; Inlow M; Moore JH; Saykin AJ; Shen L
    Multimodal Brain Image Anal (2013); 2013; 8159():202-210. PubMed ID: 25927078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning based on the multimodal connectome can predict the preclinical stage of Alzheimer's disease: a preliminary study.
    Chen H; Li W; Sheng X; Ye Q; Zhao H; Xu Y; Bai F;
    Eur Radiol; 2022 Jan; 32(1):448-459. PubMed ID: 34109489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A distributed multitask multimodal approach for the prediction of Alzheimer's disease in a longitudinal study.
    Tabarestani S; Aghili M; Eslami M; Cabrerizo M; Barreto A; Rishe N; Curiel RE; Loewenstein D; Duara R; Adjouadi M
    Neuroimage; 2020 Feb; 206():116317. PubMed ID: 31678502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and Graphical Analysis of Alzheimer's Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype.
    Gupta Y; Kim JI; Kim BC; Kwon GR
    Front Aging Neurosci; 2020; 12():238. PubMed ID: 32848713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KERNEL-BASED MULTI-TASK JOINT SPARSE CLASSIFICATION FOR ALZHEIMER'S DISEASE.
    Wang Y; Liu M; Guo L; Shen D
    Proc IEEE Int Symp Biomed Imaging; 2013 Dec; 2013():1364-1367. PubMed ID: 24443696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.